Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

I Was Preparing to Be an Oncology Nurse, That is Until My Sister's Cancer Returned

May 17th 2022

Watching my sister undergo cancer treatment made me want to become a nurse, though after she was re-diagnosed, I’ve had to step away from that career path.

Stop Saying Cancer is a 'Battle'

May 10th 2022

I can’t stand the “battle language” of cancer, including terms like “cancer warrior” and “losing the battle” with the disease.

‘Leave It to Beaver’ Star Announces Cancer Diagnosis, Woman Receives Prison Sentence for Faking Cancer Treatment to Collect Donations and More

May 6th 2022

From “Leave It to Beaver” actor Tony Dow revealing his cancer diagnosis to a woman faking a cancer diagnosis to collect $100,000 in donations and a European soccer star finishing treatment, here’s what’s happening in the cancer space this week.

My Sister's Cancer Journey Has Taught Me to Live Moment by Moment

May 5th 2022

After my sister was re-diagnosed with stage 4 cancer, I was reminded to find laughter in every day because nobody knows what tomorrow holds.

Long-Term Axi-Cel Data ‘May Be Suggestive of a Cure’ in Patients With Large B-Cell Lymphoma

April 26th 2022

The majority of patients with relapsed/refractory large B-cell lymphoma were alive between four and five years after being treated with axi-cel.

Better Data Needed to Approve Future PI3K Inhibitors for Blood Cancers, FDA Panel Recommends

April 25th 2022

A panel of experts on the FDA’s Oncologic Drugs Advisory Committee voted that all future approvals of PI3K inhibitors to treat blood cancer be backed by randomized clinical trial data.

Novel Drug Elicits High Response Rates in Relapsed/Refractory Lymphoma Subset

April 20th 2022

Findings from an early-phase clinical trial show that treatment with epcoritamab led to a 63.1% response rate in patients with pretreated large B-cell lymphoma.

Patients With Cancer Don't Owe 'Grief Tourists' Anything

April 19th 2022

After going public with my cancer diagnosis, I was met with an onslaught of “grief tourists” who may not have been interested in the harsh realities of cancer.

Has Cancer Survivorship Made Me Weak?

April 13th 2022

After surviving cancer, I’ve developed complex post-traumatic stress disorder, which comes with feelings of insecurity and anger.

First Patient With Lymphoma Receives Novel Cell Therapy in Large-Scale Trial

April 5th 2022

The plan is to assess the safety and efficacy of the genetically engineered cell therapy alongside high-dose chemotherapy and blood stem cell transplantation in approximately 150 patients with lymphoma.

FDA Approves Yescarta, First CAR-T Cell Therapy, for Patients With Large B-Cell Lymphoma That Has Failed Initial Treatment

April 4th 2022

The FDA’s decision to approve Yescarta in patients with large B-cell lymphoma that has failed to respond to first-line treatment is based on data that showed that the use of the CAR-T cell therapy resulted in a significant increase in patients who were alive at two years compared with the standard-of-care second-line treatment.

‘I Would Have Given Up a Long Time Ago’ and Other Things Not to Say to Cancer Survivors

March 23rd 2022

My survivor friends and I share the insensitive comments we have received about our cancer diagnosis.

CAR-T Cell Therapies Offer ‘An Opportunity for Majority of Patients’ With Lymphoma to Be Treated

March 14th 2022

Unlike stem cell transplant, which has strict eligibility criteria, the majority of patients with blood cancer may be able to receive CAR-T cell therapy, regardless of other comorbidities, explained an expert.

Cancer Changed My Relationship With Pain: ‘Being a Trooper’ Is Not Always a Good Thing

March 10th 2022

After seeing my brother go through extraordinary pain because of lymphoma and then surviving breast cancer myself, I always pushed through the pain — even when I shouldn’t have.

New Treatments Lend a Positive Outlook to Patients With GVHD

February 28th 2022

There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.

FDA Agrees to Review CAR-T Cell Therapy for Second-Line Treatment of Large B-Cell Lymphoma

February 17th 2022

The Food and Drug Administration will review data on Breyanzi (lisocabtagene maraleucel) — a CAR-T cell therapy — for use in the second-line setting for patients with relapsed or refractory large B-cell lymphoma to determine if the indication will be granted approval.

Supportive Care and Palliative Care May Improve Outcomes in Patients Receiving CAR-T Cell Therapy

February 14th 2022

Supportive care should be implemented promptly after patients receive CAR-T cell therapy, but as one expert notes, patients with cancer are often referred for this care too late.

Support From Beyond: How My Deceased Loved Ones Helped Me Navigate My Cancer Journey

January 24th 2022

A survivor of multiple cancers explains how “visits” from deceased friends and loved ones made her feel safe before undergoing treatments.

How I Learned to Deal With the Fact That Cancer May Never Go Away

January 21st 2022

A woman explains how she grapples with the acceptance that her sister may never enter remission from cancer.

Wearable Remote Monitoring Device May Help Patients With Blood Cancers Identify When to Seek Follow-Up Care

January 20th 2022

Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

Yescarta for Relapsed/Refractory Large B-Cell Lymphoma May Represent a ‘Paradigm Shift’ in Second-Line Treatment

January 14th 2022

CAR-T cell therapy with Yescarta in patients with relapsed/refractory large B-cell lymphoma had improved responses to treatment and survival in the second-line setting, which may help save more lives than standard care, an expert said.

Prophylactic Monoclonal Antibodies Recommended to Protect Certain Patients With Cancer From COVID-19

January 11th 2022

The National Comprehensive Cancer Network now recommends prophylactic monoclonal antibodies for immunosuppressed individuals, such as certain patients with cancer.

Trial Launched to Assess Safety and Efficacy of Novel Drug in Rare Type of Head and Neck Cancer

January 10th 2022

A phase 2 trial was recently launched to examine the safety and efficacy of oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma.

Cancer Drug Approvals from 2021 That Patients May Have Missed

December 28th 2021

2021 was full of research advancements and FDA drug approvals that continue to improve cancer care for patients with a variety of malignancies.

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23rd 2021

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

FDA Approves Orencia for GVHD Prevention After Hematopoietic Stem Cell Transplant

December 15th 2021

The Food and Drug Administration approved Orencia, which is commonly used to treat conditions like rheumatoid arthritis, to prevent acute graft-versus-host-disease in adults and children who underwent a hematopoietic stem cell transplant from an unrelated donor.

New Treatment Regimen May Reduce GvHD, the ‘Most Common and Feared Complication’ of Stem Cell Transplantation

December 14th 2021

The addition of a drug commonly used to treat arthritis may reduce the risk of graft-versus-host-disease in patients who underwent haploidentical allogeneic stem cell transplant.

Novel Drug Plus Rituxan May Serve as ‘New Treatment Option’ for Relapsed/Refractory Lymphoma Subset

December 13th 2021

The use of a novel drug combination yielded positive outcomes in patients with B-cell lymphomas for whom CAR-T cell therapy or stem cell transplant isn’t an option.

Cancer Clinical Trial Enrollment Is Low in the US, and Patient Depression and Anxiety May Play a Role

December 12th 2021

Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.

CAR-T Cell Therapy Bests Standard of Care in Health-Related Quality of Life for Patients With Lymphoma

December 11th 2021

Patients with large B-cell lymphoma tended to have better quality of life that continued to improve over time after receiving Breyzani compared to those given standard of care.

NEXT PAGE
PREVIOUS PAGE